Back to Search
Start Over
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
- Source :
- Nature medicine Advance online publication, (2022). doi:10.1038/s41591-022-02076-8
- Publication Year :
- 2022
- Subjects :
- ddc:610
General Medicine
General Biochemistry, Genetics and Molecular Biology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Nature medicine Advance online publication, (2022). doi:10.1038/s41591-022-02076-8
- Accession number :
- edsair.doi.dedup.....6c97700dd7ef99d3cd8761b59595ccd2